These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 29448911)
21. Important Role of Asparagines in Coupling the Pore and Votage-Sensor Domain in Voltage-Gated Sodium Channels. Sheets MF; Fozzard HA; Hanck DA Biophys J; 2015 Dec; 109(11):2277-86. PubMed ID: 26636939 [TBL] [Abstract][Full Text] [Related]
22. Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7. Payandeh J; Hackos DH Handb Exp Pharmacol; 2018; 246():271-306. PubMed ID: 29532179 [TBL] [Abstract][Full Text] [Related]
23. Subtype specificity of scorpion beta-toxin Tz1 interaction with voltage-gated sodium channels is determined by the pore loop of domain 3. Leipold E; Hansel A; Borges A; Heinemann SH Mol Pharmacol; 2006 Jul; 70(1):340-7. PubMed ID: 16638971 [TBL] [Abstract][Full Text] [Related]
24. Investigation into the role of an extracellular loop in mediating proton-evoked inhibition of voltage-gated sodium channels. Harms E; Stoetzer C; Stueber T; O'Reilly AO; Leffler A Neurosci Lett; 2017 Nov; 661():5-10. PubMed ID: 28939386 [TBL] [Abstract][Full Text] [Related]
25. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels. McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of the Human Neuronal Sodium Channel Na Marchese-Rojas M; Islas ÁA; Mancilla-Simbro C; Millan-PerezPeña L; León JS; Salinas-Stefanon EM Neuroscience; 2023 Feb; 511():39-52. PubMed ID: 36156289 [TBL] [Abstract][Full Text] [Related]
27. Combinatorial interaction of scorpion toxins Lqh-2, Lqh-3, and LqhalphaIT with sodium channel receptor sites-3. Leipold E; Lu S; Gordon D; Hansel A; Heinemann SH Mol Pharmacol; 2004 Mar; 65(3):685-91. PubMed ID: 14978247 [TBL] [Abstract][Full Text] [Related]
28. NMR analysis of interaction of LqhalphaIT scorpion toxin with a peptide corresponding to the D4/S3-S4 loop of insect para voltage-gated sodium channel. Schnur E; Turkov M; Kahn R; Gordon D; Gurevitz M; Anglister J Biochemistry; 2008 Jan; 47(3):911-21. PubMed ID: 18154318 [TBL] [Abstract][Full Text] [Related]
29. Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks. Harmer AR; Abi-Gerges N; Easter A; Woods A; Lawrence CL; Small BG; Valentin JP; Pollard CE J Pharmacol Toxicol Methods; 2008; 57(1):30-41. PubMed ID: 17980627 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Na Lee SJ; Kim DH; Hahn SJ; Waxman SG; Choi JS Neurosci Lett; 2017 Feb; 639():1-7. PubMed ID: 28017662 [TBL] [Abstract][Full Text] [Related]
31. Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin. Zhao F; Li X; Jin L; Zhang F; Inoue M; Yu B; Cao Z Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26891306 [TBL] [Abstract][Full Text] [Related]
32. Serine-401 as a batrachotoxin- and local anesthetic-sensing residue in the human cardiac Na+ channel. Wang SY; Tikhonov DB; Zhorov BS; Mitchell J; Wang GK Pflugers Arch; 2007 May; 454(2):277-87. PubMed ID: 17205354 [TBL] [Abstract][Full Text] [Related]
33. Molecular determinants of μ-conotoxin KIIIA interaction with the human voltage-gated sodium channel Na Kimball IH; Nguyen PT; Olivera BM; Sack JT; Yarov-Yarovoy V Front Pharmacol; 2023; 14():1156855. PubMed ID: 37007002 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel Na Kornecook TJ; Yin R; Altmann S; Be X; Berry V; Ilch CP; Jarosh M; Johnson D; Lee JH; Lehto SG; Ligutti J; Liu D; Luther J; Matson D; Ortuno D; Roberts J; Taborn K; Wang J; Weiss MM; Yu V; Zhu DXD; Fremeau RT; Moyer BD J Pharmacol Exp Ther; 2017 Jul; 362(1):146-160. PubMed ID: 28473457 [TBL] [Abstract][Full Text] [Related]
35. Insights into the binding mode and functional components of the analgesic-antitumour peptide from Zhao F; Wang JL; Ming HY; Zhang YN; Dun YQ; Zhang JH; Song YB J Biomol Struct Dyn; 2020 Apr; 38(6):1868-1879. PubMed ID: 31099313 [TBL] [Abstract][Full Text] [Related]
36. Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening. Rogers M; Zidar N; Kikelj D; Kirby RW Assay Drug Dev Technol; 2016 Mar; 14(2):109-30. PubMed ID: 26991361 [TBL] [Abstract][Full Text] [Related]
37. Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels. Sheets MF; Hanck DA J Physiol; 2007 Jul; 582(Pt 1):317-34. PubMed ID: 17510181 [TBL] [Abstract][Full Text] [Related]
38. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1. Murray JK; Long J; Zou A; Ligutti J; Andrews KL; Poppe L; Biswas K; Moyer BD; McDonough SI; Miranda LP J Med Chem; 2016 Mar; 59(6):2704-17. PubMed ID: 26890998 [TBL] [Abstract][Full Text] [Related]
39. Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel. Nguyen PT; DeMarco KR; Vorobyov I; Clancy CE; Yarov-Yarovoy V Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2945-2954. PubMed ID: 30728299 [TBL] [Abstract][Full Text] [Related]
40. In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations. Wang M; Wang Y; Kong D; Jiang H; Wang J; Cheng M Comput Biol Chem; 2018 Dec; 77():214-225. PubMed ID: 30359866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]